U.S. markets open in 54 minutes
  • S&P Futures

    4,142.75
    +24.75 (+0.60%)
     
  • Dow Futures

    33,790.00
    +166.00 (+0.49%)
     
  • Nasdaq Futures

    13,929.75
    +131.00 (+0.95%)
     
  • Russell 2000 Futures

    2,267.60
    +22.60 (+1.01%)
     
  • Crude Oil

    62.79
    -0.36 (-0.57%)
     
  • Gold

    1,751.00
    +14.70 (+0.85%)
     
  • Silver

    25.70
    +0.18 (+0.69%)
     
  • EUR/USD

    1.1982
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    1.6100
    -0.0280 (-1.71%)
     
  • Vix

    16.69
    +0.04 (+0.24%)
     
  • GBP/USD

    1.3799
    +0.0019 (+0.14%)
     
  • USD/JPY

    108.7860
    -0.1410 (-0.13%)
     
  • BTC-USD

    62,755.21
    -1,659.58 (-2.58%)
     
  • CMC Crypto 200

    1,371.16
    -4.62 (-0.34%)
     
  • FTSE 100

    6,975.95
    +36.37 (+0.52%)
     
  • Nikkei 225

    29,642.69
    +21.70 (+0.07%)
     

LAWSUITS FILED AGAINST PRA, ENPH and CEMI - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / August 10, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

ProAssurance Corporation (NYSE:PRA)

CONTACT JAKUBOWITZ ABOUT PRA:
https://claimyourloss.com/securities/proassurance-corporation-loss-submission-form/?id=8458&from=1

Class Period: April 26, 2019 - May 7, 2020

Lead Plaintiff Deadline: August 17, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) ProAssurance lacked adequate underwriting process and risk management controls necessary to set appropriate loss reserves in its Specialty P&C segment; (ii) ProAssurance failed to properly assess a large national healthcare account that experienced losses far exceeding the assumptions made when the account was underwritten; and (iii) as a result, ProAssurance was subject to materially heightened risk of financial loss and reserve charges.

Enphase Energy, Inc. (NASDAQ:ENPH)

CONTACT JAKUBOWITZ ABOUT ENPH:
https://claimyourloss.com/securities/enphase-energy-inc-loss-submission-form/?id=8458&from=1

Class Period: February 26, 2019 - June 17, 2020

Lead Plaintiff Deadline: August 17, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) its revenues, both U.S. and international, were inflated; (2) the Company engaged in improper deferred revenue accounting practices; (3) the Company's reported base points expansion in gross margins were overstated; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Chembio Diagnostics, Inc. (NASDAQ:CEMI)

CONTACT JAKUBOWITZ ABOUT CEMI:
https://claimyourloss.com/securities/chembio-diagnostics-inc-loss-submission-form/?id=8458&from=1

Class Period: March 12, 2020 - June 16, 2020

Lead Plaintiff Deadline: August 17, 2020

According to the filed complaint, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Chembio's stock price and operated as a fraud or deceit by misrepresenting the efficacy of the Company's Dual Path Platform ("DPP") COVID-19 test. Defendants allegedly achieved this by making false statements about Chembio's DPP COVID-19 test, although they knew or at least recklessly disregarded that there were material performance concerns with the test. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Chembio stock fell precipitously as the prior artificial inflation came out of Chembio's stock price.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/600981/LAWSUITS-FILED-AGAINST-PRA-ENPH-and-CEMI--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS